Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of November 2024 for Cellebrite DI Ltd., a foreign private issuer headquartered in Petah Tikva, Israel. The report is filed pursuant to Rule 13a-16 under the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary material change disclosed is a significant leadership transition. On November 6, 2024, the company announced that Yossi Carmil will step down as Chief Executive Officer after nearly 20 years of service.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the implications of the CEO departure. The press release regarding the CEO transition is furnished as Exhibit 99.1.
Investor Verification Checklist
- Verify the timeline and details of the CEO succession plan following Yossi Carmil's departure.
- Review the full text of the press release (Exhibit 99.1) for interim leadership arrangements.
- Monitor subsequent filings for the appointment of a permanent CEO.